The company will still have some catching up to do, as LM-299 is early in clinical development, with a phase 1 trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback